Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

Tunable growth factor delivery from injectable hydrogels for tissue engineering.

Katarina Vulic1, Molly S Shoichet

  • 1Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario, Canada M5S 3H6.

Journal of the American Chemical Society
|December 29, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor.

npj drug discovery·2026
Same author

Quantitative prediction of siRNA complexation by ionizable drugs enables their codelivery in nanoparticles.

Science advances·2026
Same author

Dexime: A Selectively Enzyme-Degradable Hydrogel for Protein Therapeutic Release.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

An integrated <i>i</i> <i>n vitro</i> platform and biophysical modeling approach for studying synaptic transmission in isolated neuronal pairs.

iScience·2026
Same author

A Customizable Antibody Delivery Strategy Using Fc-Affinity Ligands.

ACS biomaterials science & engineering·2026
Same author

Epigenetic maintenance of the injury response state in glioblastoma stem cells.

Neuro-oncology advances·2026
Same journal

A Ni-Mediated Cross-Coupling Approach to Deuterated <sup>18</sup>F- Fluoromethylated (Hetero)arenes.

Journal of the American Chemical Society·2026
Same journal

Efficient Light-Driven CO<sub>2</sub> Capture and Reversible Release Enabled by Metastable Photoacid-Decorated Metal-Organic Frameworks.

Journal of the American Chemical Society·2026
Same journal

In Situ Raman Spectroscopy Reveals the Dynamic Evolution and Ethanol Dependence of SEI Structure in Li-Mediated N<sub>2</sub> Reduction Reaction.

Journal of the American Chemical Society·2026
Same journal

Solvent Esterification and Stoichiometric Control in Ambient-Grown FAPbI<sub>3</sub> Single-Crystal Solar Cells.

Journal of the American Chemical Society·2026
Same journal

Unlocking Azulene Functionalization via Strain-Induced Azulyne Intermediates.

Journal of the American Chemical Society·2026
Same journal

An Oxazine-Locked Covalent Organic Framework by a Tandem Pinner/Schiff Base Reaction for Hydrogen Peroxide Photosynthesis.

Journal of the American Chemical Society·2026
See all related articles

This study introduces a novel affinity-based hydrogel system for sustained protein drug delivery. The new method extends protein therapeutic release to 10 days, improving upon current limitations.

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Protein Engineering

Background:

  • Current protein therapeutic delivery methods face limitations due to protein instability, leading to low bioactive protein levels.
  • Prolonged and controlled release of therapeutic proteins remains a significant challenge in the field.

Purpose of the Study:

  • To develop an affinity-based hydrogel system for sustained delivery of protein therapeutics.
  • To investigate the impact of varying peptide-protein binding affinities on drug release profiles.
  • To demonstrate the broad applicability of this system for delivering bioactive proteins at tunable rates.

Main Methods:

  • Methyl cellulose was modified with Src homology 3 (SH3)-binding peptides to create MC-peptide hydrogels.
  • The release of a fusion protein (SH3-rhFGF2) from hyaluronan MC-SH3 peptide (HAMC-peptide) hydrogels was studied.

More Related Videos

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

Related Experiment Videos

Last Updated: May 26, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

  • Release profiles were compared between hydrogels with different peptide affinities and unmodified controls.

    • Main Results:

    • Sustained release of SH3-rhFGF2 fusion protein was extended to 10 days using HAMC-peptide hydrogels.
    • This represents a significant improvement over the 48-hour release observed from unmodified HAMC hydrogels.
    • The rate of protein release was tunable based on the binding affinity of the incorporated peptides.

    Conclusions:

    • The developed affinity-based HAMC-peptide hydrogel system enables prolonged and tunable release of bioactive protein therapeutics.
    • This approach overcomes limitations of protein fragility and enhances therapeutic efficacy.
    • The system shows broad applicability for delivering various protein drugs with controlled release kinetics.